Related Experiment Videos

p21Cip1 nullizygosity increases tumor metastasis in irradiated mice

Rosalind J Jackson1, Robert W Engelman, Domenico Coppola

  • 1Molecular Oncology Program, H. Lee Moffitt Cancer Center and Research Institute, and Department of Interdisciplinary Oncology, University of South Florida College of Medicine, Tampa, Florida 33612, USA.

Cancer Research
|June 18, 2003
PubMed

Insights

The cyclin-dependent kinase inhibitor p21 (Cip1) suppresses tumor formation and metastasis. Studies show p21 deficiency increases tumor incidence and spread in mice exposed to radiation.

Area of Science:

  • Molecular Biology
  • Cell Cycle Regulation
  • Cancer Research

Background:

  • p21(Cip1) is a cyclin-dependent kinase inhibitor.
  • Its levels rise following DNA damage, activating a G1 checkpoint for DNA repair.
  • This checkpoint prevents entry into S phase, potentially suppressing tumor development.

Purpose of the Study:

  • To investigate the role of p21(Cip1) in tumor suppression and metastasis.
  • To determine if p21(Cip1) functions as a tumor suppressor and/or antimetastatic agent.

Main Methods:

  • Utilized p21(Cip1) heterozygous and nullizygous mice.
  • Exposed mice to a single dose of gamma-irradiation.
  • Assessed tumor incidence and metastasis rates in different genotypes.

Main Results:

  • p21(Cip1) heterozygous and nullizygous mice developed more tumors than wild-type mice after irradiation.
  • p21(Cip1) nullizygosity significantly increased the incidence of metastatic tumors in irradiated mice.
  • These findings suggest p21(Cip1) is haploinsufficient for tumor suppression.

Conclusions:

  • p21(Cip1) acts as a tumor suppressor, as evidenced by increased tumor formation in its absence.
  • p21(Cip1) exhibits antimetastatic properties, with deficiency leading to increased tumor metastasis.
  • The study highlights the dual role of p21(Cip1) in preventing both primary tumor development and metastatic spread.

Related Concept Videos